SPARCC Abstracts and Publications

Transcription

1 SPARCC Abstracts and Publications 2011 Papers 1. Gladman DD, Rahman P, Cook RJ, Shen H, Zummer M, Thomson G, Nair B, Rohekar S, Ayearst R, Inman RD, Maksymowych W. The Spondyloarthritis Research Consortium of Canada Registry for Spondyloarthritis. J Rheumatol doi: /jrheum , First Release April 15/ Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R, Collantes-Estevez E, Dagfinrud H, Dijkmans B, Dougados M, Emery P, Geher P, Hammoudeh M, Inman RD, Jongkees M, Khan MA, Kiltz U, Kvien TK, Leirisalo-Repo M, Maksymowych WP, Olivieri I, Pavelka K, Sieper J, Stanislawska-Biernat E, Wending D, Ozgocmen S, van Drogen C, van Royen BJ, van der Heijde D update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70: , Karsdal MA, Woodworth T, Henriksen K, Maksymowych WP, Genant H, Vergnaud P, Christiansen C, Schubert T, Qvist P, Schett G, Platt A, Bay-Jensen AC. Biochemical markers of ongoing joint damage in rheumatoid arthritis current and future applications, limitations and opportunities. Arthritis Res Ther 13:215-35, Pedersen SJ, Chiowchanwisawakit P, Lambert RGW, Østergaard M, Maksymowych WP. Resolution of inflammation following treatment of ankylosing spondylitis is associated with new bone formation. J Rheumatol First Release April 1, 2011:doi: /jrheum Weber U, Maksymowych WP. Sensitivity and specificity of magnetic resonance imaging for axial spondyloarthritis. Am J Med Sci 341(4):272-77, Gladman DD, Chandran V, Thavaneswaran A, Zummer M : Psoriatic arthritis (PsA) in Canadian Clinical Practice: the PsA Assessment in Rheumatology (PAIR) J. Rheumatol. In Press. 7. Kavanaugh A, McInnes IB, Krueger GG, Gladman D, Beutler A, Gathany T, Mudivarthy S, Mack M, Tandon N, Han C, Mease P, GO-REVEAL Clinical Investigators. Early and sustained remission associated with normalized physical function, health-related quality of life & significantly improved productivity in patients with active psoriatic arthritis treated with golimumab: 2-year data from phase iii GO-REVEAL trial. Ann Rheum Dis 2011;70(Suppl3): Chandran V, Ibrahim A, Thavaneswaran A, Eder L, Helliwell P, Cook J, Gladman DD. Sensitivity to change of radiographic scoring instruments in axial psoriatic arthritis. Ann Rheum Dis 9. Uddin M, Hamilton S, Eder L, Pellett F, Pope A, Peddle L, Gladman D, Rahman P. Prevalence of known obesity related genes differs between psoriatic arthritis and psoriasis. Ann Rheum Dis SPARCC Publications Nov 2011 Page 1 of 5

2 10. Kavanaugh A, van der Heijde D, Gladman D, Mease P, McInnes I, Krueger GG, Xu G, Goldstein N, Beutler A, GO-REVEAL Clinical Investigators. Long-term radiographic outcome in psoriatic arthritis patients treated with golimumab: 104 week results from the GO-REVEAL study. Ann Rheum Dis 2011;70(Suppl3):240. Abstracts 1. Morency N, Lambert R, Maksymowych W. Direct imaging evidence that adalimumab induces resolution of inflammatory lesions in AS patients at sites of complete spinal ankylosis. J Rheumatol 38(6):1138, Maksymowych W, Lambert R, Patra K, Pangan A. Defining the smallest detectable change for the SPARCC spine and sacroiliac joint MRI index for ankylosing spondylitis. J Rheumatol 38(6):1146, Haroon N, Maksymowych W, Rahman P, Tsui F, Inman R. LMP2 and ERAP1 variants are associated with radiographic severity in ankylosing spondylitis in the SPARCC Cohort. J Rheumatol 38(6):1147, Maksymowych W, van der Heijde D, Landewe R, Pangan A, Brown L, Lavie F. Predictors of radiographic progression in adalimumab-treated patients with ankylosing spondylitis. J Rheumatol 38(6):1161, Maksymowych W, Ohinmaa A, Martin L, Russell A, Barr S, Sholter D, Penney C, Charles Y, Jacobs P. Primary anti-tnf failures experience better clinical responses but similar health care utilization to a second anti-tnf angent than secondary failures: analysis of the Alberta Rheumatoid Arthritis Biologics Registry. J Rheumatol 38(6):1162, Navis C, Davis P, Maksymowych W, Yacyshyn E. Age differences in the prescription of biologics versus DMARDs. J Rheumatol 38(6):1167, Touma Z, Eder L, Zisman D, Feld J, Chandran V, Rosen C, Shen H, Cook RJ, Gladman DD: Seasonal Variation in Vitamin D Levels in Patients with Psoriatic Arthritis from Northern and Southern Latitudes and its Association with Clinical Outcomes. J. Rheumatol. In Press. 8. Pollock R, Chandran V, Barrett J, Eder L, Pellett F, Yao C, LIno M, Shanmugarajah S, Farewell V, Gladman DD: The Functional MICA-129 Polymorphism is Associated with Psoriatic Diseease Independently of HLA-B and C. J. Rheumatol. In Press. 9. Jayakar JP, Eder L, Pereira D, Thavaneswaran A, Shanmugarajah S, and Gladman DD: Prevalence of Metabolic Syndrome in Psoriasis and Psoriatic Arthritis. J. Rheumatol. In Press. 10. Gladman DD, Chandran V, Thavaneswaran A, Zummer M : Psoriatic arthritis (PsA) in Canadian Clinical Practice: the PsA Assessment in Rheumatology (PAIR) J. Rheumatol. In Press. 11. Kavanaugh A, McInnes IB, Krueger GG, Gladman D, Beutler A, Gathany T, Mudivarthy S, Mack M, Tandon N, Han C, Mease P, GO-REVEAL Clinical Investigators. Early and sustained remission associated with normalized physical function, health-related quality of life & significantly improved productivity in patients with active psoriatic arthritis treated with golimumab: 2-year data from phase iii GO-REVEAL trial. Ann Rheum Dis 2011;70(Suppl3):238. SPARCC Publications Nov 2011 Page 2 of 5

3 12. Chandran V, Ibrahim A, Thavaneswaran A, Eder L, Helliwell P, Cook J, Gladman DD. Sensitivity to change of radiographic scoring instruments in axial psoriatic arthritis. Ann Rheum Dis 13. Uddin M, Hamilton S, Eder L, Pellett F, Pope A, Peddle L, Gladman D, Rahman P. Prevalence of known obesity related genes differs between psoriatic arthritis and psoriasis. Ann Rheum Dis 14. Kavanaugh A, van der Heijde D, Gladman D, Mease P, McInnes I, Krueger GG, Xu G, Goldstein N, Beutler A, GO-REVEAL Clinical Investigators. Long-term radiographic outcome in psoriatic arthritis patients treated with golimumab: 104 week results from the GO-REVEAL study. Ann Rheum Dis 2011;70(Suppl3): Morency N, Inman RD, Rahman P, Gladman D, Conner-Spady B, Maksymowych WP. The sparcc simple (screening for inflammatory pain in the lower) back questionnaire: preliminary validation in new patients presenting with back pain. Ann Rheum Dis 2011;70(Suppl3): Chandran V, Pellett FJ, Ayearst R, Pollock RA, Gladman DD. The Interaction between Killer-cell Immunoglobulin-like Receptor Genes and HLA Alleles in Susceptibility to Psoriatic Arthritis. ASHG/ICHG 2011 Montreal, Canada, October Chandran V, Thavaneswaran A, Pellett FJ, Gladman DD. The association between Human Leukocyte Antigen and Killer-cell Immunoglobulin-like receptor gene variants and the development of Axial Arthritis among Patients with Psoriatic Arthritis. Arthritis Rheum 2011;63(supplement) 18. Chandran V, Pellett FJ, Pollock RA, Ayearst R, Rahman P, Gladman DD. Investigating the association between endoplasmic reticulum aminopeptidase 1 gene variants and psoriatic arthritis. Arthritis Rheum 2011;63(supplement) 19. Chandran V, Thavaneswaran A, Pellett FJ, Gladman DD. The association between Human Leukocyte Antigen and Killer-cell Immunoglobulin-like receptor gene variants and progression of peripheral joint damage in psoriatic arthritis. Arthritis Rheum 2011;63(supplement) 20. Eissa A, Gladman DD, Thavaneswaran A, Pellett FJ, Diamandis E, Chandran V. Serum Kallikreins as Biomarkers in Psoriatic Disease. Arthritis Rheum 2011;63(supplement) 21. Pollock RA, Pellett FJ, Ayearst R, Rahman P, Gladman DD, Chandran V. Extended Haplotypes Between Human Leukocyte Antigen - C and Tumour Necrosis Factor A gene loci Reveal Psoriatic Arthritis Susceptibility Hotspots. Arthritis Rheum 2011;63(supplement) 22. Chandran V, Thavaneswaran A, Pellett FJ, Gladman DD. The association between Human Leukocyte Antigen and Killer-cell Immunoglobulin-like receptor gene variants and the development of arthritis mutilans in patients with psoriatic arthritis. Arthritis Rheum 2011;63(supplement) 23. Chandran V, Pellett FJ, Thavaneswaran A, Pollock RA, Ayearst R, Gladman DD. Association between Human Leukocyte Antigen and Killer-cell Immunoglobulin-like receptor gene variants and type II psoriasis and dactylitis in Psoriatic Arthritis. Arthritis Rheum 2011;63(supplement) SPARCC Publications Nov 2011 Page 3 of 5

4 24. Chandran V, Pellett FJ, Rahman P, Gladman DD. Family based association study confirms human leukocyte antigen allele associations with psoriatic arthritis. Arthritis Rheum 2011;63(supplement) 25. Chandran V, Ibrahim A, Thavaneswaran A, Eder L, Helliwell P, Cook RJ, Gladman DD. Radiographic scoring instruments have high specificity for detecting change in axial psoriatic arthritis. Arthritis Rheum 2011;63(supplement) 26. Cretu D, Gladman DD, Pellett FJ, Diamandis E, Chandran V. Proteomic Profiling of Synovial Fluid for the Identification of Psoriatic Arthritis Soluble Biomarkers. Arthritis Rheum 2011;63(supplement) (AcceptedGladman DD, Cook RJ, Eder L, Wakhlu A, Riddell C, Ostergaard M, Thavaneswaran A, Chandran V. Does clinical examination underestimate joint inflammation in patients with psoriatic arthritis? Arthritis Rheum 2011;63(supplement) 27. Gladman DD, Ayearst A, Chandran V, Dutz JP, Elder JT, Ritchlin C, Rosen CF, Rahman P. Comparison Between Psoriasis and Psoriatic Arthritis in an International Cohort. Arthritis Rheum 2011;63(supplement) 28. Eder L, Pellett FJ, Chandran V, Shanmugarajah S, Bull SB, Gladman DD. Differential Human Leukocyte Allele Association between Psoriasis and Psoriatic Arthritis A Family-Based Association study. Arthritis Rheum 2011;63(supplement) 29. Eder L, Thavaneswaran A, Chandran V, Gladman DD. Anti TNFα agents are more effective than methotrexate in preventing radiographic joint damage among patients with Psoriatic Arthritis in a clinic setting. Arthritis Rheum 2011;63(supplement) 30. Eder L, Thavaneswaran A, Chandran V, Gladman DD. Gender related differences in severity of Psoriatic arthritis. Arthritis Rheum 2011;63(Supplement) Accepted. 31. Eder L, Jayakar J, Shanmugarajah S, Thavaneswaran A, Pereira D, Chandran V, Rosen CF, Gladman DD. The Prevalence of Carotid Artery Plaques Is Higher in Patients with Psoriatic Arthritis Compared to Those with Psoriasis Alone. Arthritis Rheum 2011;63(supplement) 32. Eder L, Pollock RA, Pellett FJ, Jayakar J, Thavaneswaran A, Pereira D, Rosen CF, Chandran V, Gladman DD. Serum levels of Adiponectin and Insulin Resistance are increased in patients with Psoriatic Arthritis compared to those with Psoriasis alone. Arthritis Rheum 2011;63(supplement) 33. Abufayyah M, Salonen D, Thavaneswaran A, Chandran V, Gladman DD. Radiological Characteristics of the Calcaneal Spurs in Psoriatic Arthritis. Arthritis Rheum 2011;63(supplement) 34. Haddad A, Thavaneswaran A, Chandran V, Gladman DD. The incidence of infection in psoriatic arthritis - results from longitudinal observational cohort. Arthritis Rheum 2011;63(supplement) 35. Asiri A, Thavaneswaran A, Chandran V, Kalman-Lamb G, Gladman DD. The effectiveness of Leflunomide in Psoriatic Arthritis. Arthritis Rheum 2011;63(supplement) SPARCC Publications Nov 2011 Page 4 of 5

5 36. Touma Z, Thavaneswaran A, Chandran V, Gladman DD. Does the change in season affect disease outcomes in patients with psoriatic arthritis? Arthritis Rheum 2011;63(supplement) 37. Chiu YG, Shanmugarajah S, Panepento B, Moorehead S, Eder L, Chandran V, Gladman DD, Ritchlin CT. Expression of DC-STAMP (Dendritic Cell-Specific Transmembrane Protein) and Osteoclast Precursor (OCP) Frequency in Psoriasis (PsC) patients who develop Psoriatic Arthritis (PsA). Arthritis Rheum 2011;63(supplement) 38. Eder L, Chandran V, Pellet F, Shanmugarajah S, Rosen CF, Bull SB, Gladman DD. HLA- B*27 and HLA-C*0602 are risk alleles for psoriatic arthritis among psoriasis patients. British Journal of Dermatology 39. Eder L, Shanmugarajah S, Thavaneswaran A, Chandran V, Rosen CF, Cook RJ, Gladman DD. Gene environment interaction in psoriasis and psoriatic arthritis: smoking and HLA-C*0602. British Journal of Dermatology SPARCC Publications Nov 2011 Page 5 of 5